Moffitt Scientists Present Groundbreaking Clinical Research at ASCO

Using First-of-its-Kind Vaccine to Treat Leptomeningeal Disease

Dendritic cell vaccine may prolong survival well past dismal prognosis

Evaluating the Microbiome in Patients with Triple Negative Breast Cancer

Moffitt-led Pilot study looked at gut microbiome as biomarker for treatment response

New Combination Therapy Brings Hope to Bladder Cancer Patients

Innovative treatment shows high success rates in overcoming standard therapy resistance

Personalized Vaccine Shows Promise in Merkel Cell Carcinoma

More than half of patients responded to checkpoint inhibitor rechallenge following treatment with vaccine containing streptococcus bacterial antigen

‘Daily Diary’ Study Monitors Caregiver Stress and Mood

It’s part of a larger study to support caregivers and improve patient outcomes

Could a Quick Electronic Assessment Improve Outcomes for Older People with Pancreatic Cancer?

Study shows correlation between electronic frailty index and chemotherapy toxicity among octogenarians

Addressing Racial and Ethnic Low Participation in Cancer Clinical Trials

Moffitt study examines minority perspectives on clinical trial participation

Next Generation of TIL Therapy Being Developed for Head and Neck Cancers

Standard of care fails 80% of patients with advanced squamous cell carcinoma